Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice
- PMID: 15382041
- DOI: 10.1002/ijc.20484
Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice
Abstract
Members of the signal transducers and activators of transcription (Stat) family regulate essential cellular growth and survival functions in normal cells and have also been implicated in tumorigenesis. We have studied the potential role of Stat5 in mammary tumorigenesis by _targeting Stat5 variants to the mammary gland of transgenic mice using regulatory sequences of the beta-lactoglobulin gene. Mammary-directed expression of the wild-type Stat5, constitutively activated Stat5 and carboxyl-terminally truncated dominant negative Stat5 forms resulted in mammary tumors with incidence rates of up to 22% and latency periods of 8-12 months. Undifferentiated carcinomas most frequently occurred in mice expressing the carboxyl-terminally truncated Stat5. The more differentiated papillary and micropapillary adenocarcinomas were primarily found in mice overexpressing the native and constitutively active transgenes. Higher levels of translation initiation factor 4E (eIF4E) and cyclin D1 expression but lower levels of activated Stat3 were found in tumors of mice expressing the constitutively active Stat5 when compared to mice expressing the wild-type or truncated forms. A higher expression of the estrogen receptor (ERalpha) was observed in carcinomas compared to other phenotypes. The ability of both forms of Stat5, the transactivating form and the dominant negative form, to participate in oncogenesis indicates that there is more than one mechanism by which Stat5 contributes to this process. The transactivation function of Stat5 is involved in the determination of tumors with a more differentiated phenotype.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.Mol Cancer Res. 2002 Nov;1(1):32-47. Mol Cancer Res. 2002. PMID: 12496367
-
Expression of a carboxy terminally truncated Stat5 with no transactivation domain in the mammary glands of transgenic mice inhibits cell proliferation during pregnancy, delays onset of milk secretion, and induces apoptosis upon involution.Mol Reprod Dev. 2006 Jul;73(7):841-9. doi: 10.1002/mrd.20479. Mol Reprod Dev. 2006. PMID: 16596634
-
Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.Cancer Res. 2005 Aug 1;65(15):6864-73. doi: 10.1158/0008-5472.CAN-05-0181. Cancer Res. 2005. PMID: 16061670
-
The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3.Adv Exp Med Biol. 2000;480:129-38. doi: 10.1007/0-306-46832-8_16. Adv Exp Med Biol. 2000. PMID: 10959419 Review.
-
The role of STATs in transcriptional control and their impact on cellular function.Oncogene. 2000 May 15;19(21):2468-73. doi: 10.1038/sj.onc.1203476. Oncogene. 2000. PMID: 10851045 Review.
Cited by
-
STAT signaling in mammary gland differentiation, cell survival and tumorigenesis.Mol Cell Endocrinol. 2014 Jan 25;382(1):560-569. doi: 10.1016/j.mce.2013.03.014. Epub 2013 Mar 28. Mol Cell Endocrinol. 2014. PMID: 23541951 Free PMC article. Review.
-
G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors.FEBS Open Bio. 2022 Jul;12(7):1268-1285. doi: 10.1002/2211-5463.13445. Epub 2022 Jun 9. FEBS Open Bio. 2022. PMID: 35612789 Free PMC article. Review.
-
Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression.Cancer Res. 2011 Dec 15;71(24):7513-24. doi: 10.1158/0008-5472.CAN-11-1783. Epub 2011 Oct 28. Cancer Res. 2011. PMID: 22037875 Free PMC article.
-
Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.J Biol Chem. 2018 Feb 23;293(8):2850-2864. doi: 10.1074/jbc.RA117.000162. Epub 2018 Jan 10. J Biol Chem. 2018. PMID: 29321207 Free PMC article.
-
Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.Cancer Res. 2006 Feb 15;66(4):1923-8. doi: 10.1158/0008-5472.CAN-05-1237. Cancer Res. 2006. PMID: 16488990 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous